bcl-2 delay of alkylating agent-induced apoptotic death in a murine hemopoietic stem cell line.
AuthorsFairbairn, Leslie J
Cowling, Graham J
Dexter, T Michael
Rafferty, Joseph A
Margison, Geoffrey P
Reipert, Brigit M
AffiliationCRC Department of Experimental Haematology, Paterson Institute for Cancer Research, Christie Hospital National Health Service Trust, Manchester, United Kingdom.
MetadataShow full item record
AbstractMany cytotoxic agents kill cells by invoking a specific death pathway termed physiological cell death, or apoptosis. Treatment of a murine hemopoietic stem cell line, FDCP-mix, with methylmethanesulfonate (MMS) or N'-methyl-N'-nitrosourea (MNU) leads to death by apoptosis. Retroviral gene transfer was used to overexpress the bcl-2 oncogene in FDCP-mix cells, and this was associated with a delay in apoptosis in these cells after treatment with MNU and MMS and decreased sensitivity of colony formation to the cytotoxic effects of MMS. These data suggest an explanation for the refractory nature of bcl-2-expressing follicular lymphoma to cytotoxic chemotherapy and furthermore suggest that DNA-damaging antitumor therapy may contribute to the progression of disease.
Citationbcl-2 delay of alkylating agent-induced apoptotic death in a murine hemopoietic stem cell line. 1994, 11 (1):49-55 Mol. Carcinog.
- Apaf-1 deficient mouse fibroblasts are resistant to MNNG and MMS-induced apoptotic death without attenuation of Bcl-2 decline.
- Authors: Tomicic MT, Christmann M, Fabian K, Kaina B
- Issue date: 2005 Sep 1
- Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells.
- Authors: Francis JM, Heyworth CM, Spooncer E, Pierce A, Dexter TM, Whetton AD
- Issue date: 2000 Dec 15
- Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
- Authors: Walker A, Taylor ST, Hickman JA, Dive C
- Issue date: 1997 May 15
- Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
- Authors: Kuo ML, Chou YW, Chau YP, Huang TS
- Issue date: 1997 Apr
- Specific and rapid induction of the proapoptotic protein Hrk after growth factor withdrawal in hematopoietic progenitor cells.
- Authors: Sanz C, Benito A, Inohara N, Ekhterae D, Nunez G, Fernandez-Luna JL
- Issue date: 2000 May 1